Abpro Bio Co., Ltd.

Equities

A195990

KR7195990007

Industrial Machinery & Equipment

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-07-07 pm EDT			5-day change	1st Jan Change
471 ^KRW	+0.21%		-1.05%	-13.58%

Jun. 17	Abpro Bio Co., Ltd. announced that it has received KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	CI
Jun. 13	Abpro Bio Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	CI

SM Fund acquired an additional 1.59% stake in UGint Co., Ltd. for KRW 3.6 billion.

August 30, 2017

SM Fund acquired an additional 1.59% stake in UGint Co., Ltd. (KOSDAQ:A195990) for KRW 3.6 billion on August 30, 2017. SM Fund acquired 5.85 million shares at price of KRW 617 per share and increased holding to 7.35 million shares. SM Fund will use own funds of KRW 3.6 billion to fund the transaction. SM Fund completed the acquisition of an additional 1.59% stake in UGint Co., Ltd. (KOSDAQ:A195990) on August 30, 2017.

Latest news about Abpro Bio Co., Ltd.

Abpro Bio Co., Ltd. announced that it has received KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	Jun. 16	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Sangsangin Investment & Securities Co.,Ltd., Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	Jun. 12	CI
Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim.	22-12-15	CI
Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim for KRW 37 billion.	22-09-25	CI
Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding	21-12-23	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding	21-10-13	CI
Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm	21-06-17	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm	21-06-15	CI
KUKBO Logistics Co.,Ltd acquired 19.35% stake in Bog International Co., Ltd. from Abpro Bio Co., Ltd. for KRW 2.8 billion.	20-12-21	CI
Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd., Abpro Bio Co., Ltd.	20-12-14	CI
Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.	20-11-25	CI
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd. and other investors	20-11-17	CI
An unknown buyer cancelled the acquisition of 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd..	20-10-24	CI
Microtech Co.,Ltd cancelled the acquisition of 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. from Abpro Bio Co., Ltd..	20-10-22	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.	20-10-21	CI
Abpro Bio Co., Ltd.(KOSDAQ:A195990) added to S&P Global BMI Index	20-09-21	CI
An unknown buyer agreed to acquire 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd. for KRW 3.2 billion.	19-12-30	CI
Microtech Co.,Ltd agreed to acquire 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. for KRW 6.8 billion.	19-11-28	CI
Abpro Bio International, Inc. announced that it has received KRW 18.6608 billion in funding from Abpro Bio Co., Ltd.	19-11-17	CI
Abpro Bio Co., Ltd. announced that it has received KRW 19.999999134 billion in funding	19-11-13	CI
Abpro Bio Co., Ltd. announced that it has received KRW 14 billion in funding	19-10-30	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 14 billion in funding	19-10-28	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 19.999997712 billion in funding	19-08-26	CI
Ugint CO., Ltd. announced that it has received KRW 14.322 billion in funding	19-08-22	CI

Chart Abpro Bio Co., Ltd.

Duration

Period

More charts

Company Profile

Abpro Bio Co., Ltd., formerly Ugint Co., Ltd., is a Korea-based company engaged in machine tools manufacturing. The Company produces and distributes small sized machining centers for notebooks, smart phones, tablet personal computers, mobile phones, base plates, light emitting diode (LED) and light crystal display (LCD) television panels, automobile parts, motorbikes parts and aircraft parts. The Company also engages in original equipment manufacturing business (OEM). The Company operates its business within domestic markets and foreign markets such as China and Europe countries.

Sector

Industrial Machinery & Equipment

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Machine Tools

	1st Jan change	Capi.
ABPRO BIO CO., LTD.	-13.58%	96.99M
DMG MORI CO., LTD.	+52.68%	3.64B
KENNAMETAL INC.	-11.01%	1.81B
SHENYANG MACHINE TOOL CO., LTD.	-18.73%	1.6B
KINIK COMPANY	+79.69%	1.54B
NINGBO HAITIAN PRECISION MACHINERY CO.,LTD.	-20.84%	1.49B
SHENZHEN YINGHE TECHNOLOGY CO., LTD	-15.08%	1.39B
GUANGDONG CREATE CENTURY INTELLIGENT EQUIPMENT GROUP CORPORATION LIMITED	-16.43%	1.21B
OSG CORPORATION	-4.75%	1.08B
MAX CO., LTD.	+14.00%	1.07B

Machine Tools